| Patent application number | Description | Published |
|---|
| 20090258938 | Administration of 6'-ethyl lepimectin, 6' -methyl lepimectin or derivatives thereof for treating dermatological disorders in humans - 6′-ethyl lepimectin, 6′-methyl lepimectin or derivatives thereof are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea. | 10-15-2009 |
| 20090264378 | Avermectin compounds and treatment of dermatological disorders in humans therewith - Compounds of the avermectin family or derivatives thereof, notably emamectins are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea. | 10-22-2009 |
| 20090264516 | Milbemycin compounds and treatment of dermatological disorders in humans therewith - Compounds of the milbemycin family or derivatives thereof are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea. | 10-22-2009 |
| 20090264517 | Milbemycin compounds and treatment of dermatological disorders in humans therewith - Compounds of the milbemycin family or derivatives thereof are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea. | 10-22-2009 |
| 20090281175 | Avermectin compounds and treatment of dermatological disorders in humans therewith - Compounds of the avermectin family or derivatives thereof, notably latidectin, are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea. | 11-12-2009 |
| 20090312429 | Administration of nepafenac or derivatives thereof for treating dermatological/keratinization disorders - Nepafenac or derivatives thereof are useful for the treatment of dermatological conditions related to a keratinization disorder that may have an inflammatory immunoallergic component, for example rosacea, acne, psoriasis or atopic dermatitis. | 12-17-2009 |
| 20120004295 | ADMINISTRATION OF 6'-ETHYL LEPIMECTIN, 6'-METHYL LEPIMECTIN OR DERIVATIVES THEREOF FOR TREATING DERMATOLOGICAL DISORDERS IN HUMANS - 6′-ethyl lepimectin, 6′-methyl lepimectin or derivatives thereof are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea. | 01-05-2012 |
